Biogen Balance Sheet
NASDAQ: BIIBHealth CareBiotechnology: Biological Products (No Diagnostic Substances)USD
At close: Oct 9, 4:00 PM ET · Delayed 15 min
Pre-market: 230.50 +2.12%
Biogen financial position
At the end of fiscal 2025, Biogen reported total assets of $29.44 billion, up 5.0% from a year earlier against total liabilities of $11.18 billion. Shareholders' equity stood at $18.26 billion, or 62.0% of assets. The company held $3.01 billion in cash and equivalents against $6.29 billion of debt, a net debt position of $3.28 billion.
The current ratio (current assets divided by current liabilities) was 2.68, meaning short-term assets cover obligations due within a year. Debt-to-equity was 0.34.
Summary generated from market data by MetaCap's automated system. Methodology
Biogen balance sheet (annual)
| Fiscal year (USD) | FY 20252025-12-31 | FY 20242024-12-31 | FY 20232023-12-31 | FY 20222022-12-31 | FY 20212021-12-31 | FY 20202020-12-31 | FY 20192019-12-31 | FY 20182018-12-31 | FY 20172017-12-31 | FY 20162016-12-31 |
|---|---|---|---|---|---|---|---|---|---|---|
| Cash & Equivalents | 3.01B | 2.38B | 1.05B | 3.42B | 2.26B | 1.33B | 2.91B | 1.22B | 1.57B | 2.33B |
| Short-Term Investments | 807.20M | 0 | 0 | 1.47B | 1.54B | 1.28B | 1.56B | 2.31B | 2.12B | 2.57B |
| Receivables | 1.34B | 1.40B | 1.66B | 1.71B | 1.55B | 1.91B | 1.88B | 1.96B | 1.79B | 1.44B |
| Inventory | 2.17B | 2.46B | 2.53B | 1.34B | 1.35B | 1.07B | 804.20M | 929.90M | 902.70M | 1.00B |
| Total Current Assets | 8.97B | 7.46B | 6.86B | 9.79B | 7.86B | 6.89B | 8.38B | 7.64B | 7.87B | 8.73B |
| Property, Plant & Equipment | 3.06B | 3.18B | 3.31B | 3.30B | 3.42B | 3.41B | 3.25B | 3.60B | 3.18B | 2.50B |
| Goodwill | 6.49B | 6.48B | 6.22B | 5.75B | 5.76B | 5.76B | 5.76B | 5.71B | 4.63B | 3.67B |
| Intangible Assets | 9.18B | 9.69B | 8.36B | 1.85B | 2.22B | 3.08B | 3.53B | 3.12B | 3.88B | 3.81B |
| Long-Term Investments | 431.90M | 0 | 0 | 705.70M | 892.00M | 772.10M | 1.41B | 1.38B | 3.06B | — |
| Total Assets | 29.44B | 28.05B | 26.84B | 24.55B | 23.88B | 24.62B | 27.23B | 25.29B | 23.65B | 22.88B |
| Accounts Payable | 432.00M | 424.20M | 403.30M | 491.50M | 589.20M | 454.90M | 530.80M | 370.50M | 395.50M | 279.80M |
| Short-Term Debt | 0 | 1.75B | 150.00M | 0 | 999.10M | 0 | 1.50B | 0 | 3.20M | 4.70M |
| Total Current Liabilities | 3.35B | 5.53B | 3.43B | 3.27B | 4.30B | 3.74B | 4.86B | 3.30B | 3.37B | 3.42B |
| Long-Term Debt | 6.29B | 4.55B | 6.79B | 6.28B | 7.57B | 7.50B | 6.00B | 6.00B | 0 | 16.40M |
| Total Liabilities | 11.18B | 11.33B | 12.05B | 11.17B | 12.92B | 13.93B | 13.90B | 12.26B | 11.05B | 10.75B |
| Shareholders' Equity | 18.26B | 16.72B | 14.80B | 13.40B | 10.90B | 10.70B | 13.34B | 13.04B | 12.61B | 12.14B |
| Retained Earnings | 20.55B | 19.26B | 17.63B | 16.47B | 13.91B | 13.98B | 16.46B | 16.26B | 15.81B | 15.07B |
| Total Debt | 6.29B | 6.30B | 6.94B | 6.28B | 8.57B | 7.50B | 7.50B | 6.00B | 3.20M | 21.10M |
| Net Cash (Debt) | -2.47B | -3.92B | -5.89B | -1.39B | -4.76B | -4.89B | -3.02B | -2.46B | 3.69B | 4.87B |
| Shares Outstanding | 146.80M | 145.80M | 144.90M | 144.00M | 147.00M | 152.40M | 174.20M | 197.20M | 211.50M | 215.90M |
This table shows 10 annual periods of Biogen's balance sheet, from FY 2025 back to FY 2016, across 20 line items including cash & equivalents, short-term investments, receivables. Values in USD; B = billions, M = millions. Fiscal periods follow BIIB's reporting calendar. What is a balance sheet?